273.71MMarket Cap-8666P/E (TTM)
11.420High10.890Low37.09KVolume10.990Open10.890Pre Close412.67KTurnover0.17%Turnover RatioLossP/E (Static)24.48MShares11.69052wk High5.97P/B249.18MFloat Cap7.11052wk Low--Dividend TTM22.29MShs Float28.970Historical High--Div YieldTTM4.87%Amplitude3.100Historical Low11.124Avg Price1Lot Size
Profound Medical Stock Forum
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
Profound Medical announced the U.S. Centers for Medicare and Medicaid Services (CMS) proposed a Category 1 CPT code for Transurethral Ultrasound Ablation (TULSA), effective January 1, 2025. This includes three physician codes for different procedural scenarios, introducing greater billing flexibility for pre and post-procedure visits.
TULSA will be recognize...
NEWS
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
Profound Medical Corp.'s TULSA procedure is gaining recognition as a mainstream treatment for prostate diseases, with 25 scientific research presentations this year alone. The clinical evidence showcases TULSA's efficacy in treating a diverse range of patients with localized prostate c...
No comment yet